Table 2. Baseline inner diameter and vessel wall [Ca2+]i in pulmonary and mesenteric arteries treated with vehicle, diltiazem (50 μM), PcTX1 (20 nM), or AnCoA4 (20 μM).
| Pulmonary | Mesenteric | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diameter | P-Value | Fura-2 ratio (F340/F380) | P-Value | N | Diameter | P-Value | Fura-2 ratio (F340/F380) | P-Value | N | |
| (μm) | (μm) | |||||||||
| Vehicle | 124 ± 7 | 0.79 ± 0.06 | 7 | 149 ± 15 | 0.66 ± 0.06 | 6 | ||||
| Diltiazem | 125 ± 19 | >0.9999 | 0.61 ± 0.11 | 0.9665 | 4 | 165 ± 12 | 0.8575 | 0.64 ± 0.02 | 0.9823 | 6 |
| PcTX1 | 119 ± 9 | 0.9763 | 0.82 ± 0.06 | 0.9699 | 7 | 166 ± 11 | 0.8648 | 0.75 ± 0.03 | 0.5156 | 5 |
| AnCoA4 | 122 ± 11 | 0.9982 | 0.78 ± 0.06 | 0.9999 | 7 | 139 ± 17 | 0.9535 | 0.59 ± 0.05 | 0.6305 | 7 |